BCRX - BioCryst Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCRX is currently covered by 11 analysts with an average price target of $17.53. This is a potential upside of $7.56 (75.83%) from yesterday's end of day stock price of $9.97.

BioCryst Pharmaceuticals's activity chart (see below) currently has 144 price targets and 135 ratings on display. The stock rating distribution of BCRX is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.05% with an average time for these price targets to be met of 334.36 days.

Highest price target for BCRX is $30, Lowest price target is $11, average price target is $15.91.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 07-May-2025. First documented stock forecast 17-Feb-2014.

Currently out of the existing stock ratings of BCRX, 33 are a BUY (91.67%), 3 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$11

$1.03 (10.33%)

$8

4 days ago
(07-May-2025)

8/12 (66.67%)

$0.92 (9.13%)

63

Buy

$13

$3.03 (30.39%)

$10

5 days ago
(06-May-2025)

4/6 (66.67%)

$2.73 (26.58%)

307

Buy

$17

$7.03 (70.51%)

$15

5 days ago
(06-May-2025)

3/13 (23.08%)

$6.73 (65.53%)

348

Buy

$13

$3.03 (30.39%)

$11

5 days ago
(06-May-2025)

24/25 (96%)

$2.73 (26.58%)

468

Buy

$30

$20.03 (200.90%)

$30

5 days ago
(06-May-2025)

2/8 (25%)

$19.73 (192.11%)

245

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?

On average it took 334.36 days on average for the stock forecasts to be realized with a an average price target met ratio 55.05

Which analyst has the current highest performing score on BCRX (BioCryst Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein works at HC WAINWRIGHT and has 22 price targets and 18 ratings on BCRX

Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein with highest potential upside - $20.03

Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?

Justin Kim with lowest potential downside - -$0

BioCryst Pharmaceuticals in the News

Best Momentum Stocks to Buy for May 9th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 9th: BioCryst Pharmaceuticals, Inc. BCRX: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 285.7% over the last 60 days. BioCryst Pharmaceuticals, Inc. Price and ConsensusBioCryst Pharmaceuticals,...

Why BioCryst (BCRX) Might be Well Poised for a Surge

BioCryst Pharmaceuticals (BCRX) could be a solid choice for investors given the company’s remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company. Analysts’ growing optimism on the earnings prospects of this drugmaker is driving estimates higher,...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?